lumykras
amgen europe bv - sotorasib - karcinóma, nem kissejtes tüdő - daganatellenes szerek - lumykras as monotherapy is indicated for the treatment of adults with advanced non-small cell lung cancer (nsclc) with kras g12c mutation and who have progressed after at least one prior line of systemic therapy.
apretude
viiv healthcare b.v. - cabotegravir - hiv fertőzések - vírusellenes szerek szisztémás alkalmazásra - apretude is indicated in combination with safer sex practices for pre-exposure prophylaxis (prep) to reduce the risk of sexually acquired hiv-1 infection in high-risk adults and adolescents, weighing at least 35 kg (see sections 4. 2, 4. 4 és 5.
orserdu
stemline therapeutics b.v. - elacestrant - mellnövekedés - endokrin terápia - orserdu monotherapy is indicated for the treatment of postmenopausal women, and men, with estrogen receptor (er) positive, her2-negative, locally advanced or metastatic breast cancer with an activating esr1 mutation who have disease progression following at least one line of endocrine therapy including a cdk 4/6 inhibitor.
anamataz 1 mg filmtabletta
teva gyógyszergyár zrt. - anasztrozol -
lotrimin krém
schering-plough central east ag - információ -
lotriderm krém
schering-plough central east ag - betamethasone; ezek -
perderm kenőcs
schering-plough central east ag - alklometazon -
perderm krém
schering-plough central east ag - alklometazon -
diprogenta krém
schering-plough central east ag - betamethasone -
diprogenta kenőcs
schering-plough central east ag - betamethasone -